SHARE THIS VIDEO —
Wegovy may lower risk of cardiovascular threat, drugmaker’s study shows
Catch up with NBC News Clone on today's hot topic: Mmvo190387269719 - Breaking News | NBC News Clone. Our editorial team reformatted this story for clarity and speed.
A new study from Novo Nordisk has found that its weight loss drug Wegovy may lower the risk of cardiovascular threat in overweight or obese individuals. NBC News’ Anne Thompson joins Lester Holt to discuss this finding.
Want more summaries like this? Follow NBC News Clone for expertly filtered news from trusted sources.
